Back to Search
Start Over
Cost-effectiveness of once-weekly semaglutide versus dulaglutide and lixisenatide in patients with type 2 diabetes with inadequate glycemic control in Sweden.
- Source :
- Journal of Medical Economics; Oct2019, Vol. 22 Issue 10, p997-1005, 9p
- Publication Year :
- 2019
Details
- Language :
- English
- ISSN :
- 13696998
- Volume :
- 22
- Issue :
- 10
- Database :
- Complementary Index
- Journal :
- Journal of Medical Economics
- Publication Type :
- Academic Journal
- Accession number :
- 138615157
- Full Text :
- https://doi.org/10.1080/13696998.2019.1614009